`
Home
Home » companies

Social Media Monitoring Page for Acorda Therapeutics

latest blog entries

Loading...
Branding...

latest headlines for company on cafepharma

Acorda: A Biotech Company To Consider
Seeking Alpha
Sat, 04/13/13 - 11:41 am
tags: Acorda Therapeutics
Acorda Therapeutics Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Wed, 02/13/13 - 12:02 pm
tags: Acorda Therapeutics, earnings
Banking on Biotech
CNBC
Sat, 01/12/13 - 11:33 am
tags: Acorda Therapeutics, Alexion, Biogen Idec, Biomarin, Bristol-Myers Squibb, Celgene, Cerner, Eli Lilly, EXACT Sciences, NPS Pharmaceuticals, Pfizer, Regeneron, Sanofi
Potentially game changing data awaits Acorda in 2013
Reuters
Fri, 12/21/12 - 11:42 am
tags: Acorda Therapeutics, AMPYRA, stroke
Four Important Biotech Stocks Targeting Unmet Needs
Motley Fool
Tue, 09/04/12 - 11:08 am
tags: Acorda Therapeutics, Amarin, Nektar, Neurocrine Biosciences
Acorda Therapeutics posts 2nd-quarter profit as sales and royalties from MS drug rise
Yahoo/AP
Tue, 07/31/12 - 1:26 pm
tags: Acorda Therapeutics, earnings
Even With Teva's Patent Ruling, The Company Is Only Covered Until 2015
Seeking Alpha
Mon, 06/25/12 - 11:22 am
tags: Acorda Therapeutics, Copaxone, Momenta, MS, multiple sclerosis, Mylan, Natco, patents, Teva Pharmaceuticals
6 High-Growth Biotech Stocks Analysts Rate As Buys
Seeking Alpha
Fri, 05/18/12 - 5:18 pm
tags: Acorda Therapeutics, Affymax, Alexion, Athersys, Bacterin, Biomarin
Acorda Therapeutics To FDA: What Deadlines?
Pharmalot
Thu, 05/17/12 - 10:23 am
tags: Acorda Therapeutics, adverse events, AMPYRA, FDA
BIO CEO Confab Live Blog: Day 2
TheStreet.com
Tue, 02/14/12 - 12:29 pm
tags: Acorda Therapeutics, BIO CEO Conference, Delcath, Gilead, Human Genome Sciences, Indenix, Keryx, Oncothyreon, Pfizer
20 Biotech Stocks That Hedge Funds Are Selling
Seeking Alpha
Sun, 12/11/11 - 3:40 pm
tags: Acorda Therapeutics, Amgen, BioSpecifics Technologies, Cadence Pharmaceuticals, Charles River Laboratories, Chelsea Therapeutics, Dendreon, Enzon, Insmed, Jazz Pharmaceuticals, Momenta, Nabi, Pacific Biosciences, PDL Biopharma, Sangamo BioSciences, ShangPharma, Sinovac Biotech, Transcept, Vanda, ViroPharma
Relatively Low Operating Margin Detected in Shares of BioMarin Pharmaceutical in the Biotechnology Industry (BMRN, SUPG, ACOR, CPHD, GHDX)
Investor's Business Daily
Sun, 10/09/11 - 3:51 pm
tags: Acorda Therapeutics, Biomarin, Cepheid, Genomic Health, Supergen
7 Possible Biotech Takeover Targets
Seeking Alpha
Sun, 09/18/11 - 12:02 pm
tags: Acorda Therapeutics, Amarin, Dendreon, Exelixis, Human Genome Sciences, Lexicon Pharmaceuticals, Vertex Pharmaceuticals
10 Biotech Stocks Being Dumped By Big Money Managers
Seeking Alpha
Tue, 08/30/11 - 8:36 am
tags: Acorda Therapeutics, Albany Molecular Research, Arena Pharmaceuticals, Cephalon, Charles River Laboratories, Dyax, Nektar, QLT, Questcor Pharmaceuticals, Vanda
3 Undervalued Biotechs With Buyout Potential
Seeking Alpha
Wed, 08/03/11 - 11:08 am
tags: Abbott Laboratories, Acorda Therapeutics, Adeona, Biogen Idec, Elan, M&A
Acorda Therapeutics narrows 2nd quarter loss as Amprya sales, expenses climb
Yahoo/AP
Mon, 08/01/11 - 10:29 am
tags: Acorda Therapeutics, earnings
10 Biotech Takeover/LBO Targets With Bullish Options Sentiment
Seeking Alpha
Thu, 07/21/11 - 12:21 pm
tags: Acorda Therapeutics, Alnylam, Amgen, Biomarin, Celgene, Chelsea Therapeutics, Dendreon, Exelixis, Human Genome Sciences, InterMune, M&A
5 Biotech Drug-Launch Stocks to Watch
TheStreet.com
Mon, 07/18/11 - 10:03 am
tags: Acorda Therapeutics, AMPYRA, Avanir, Benlysta, Dendreon, hepatitis C, Human Genome Sciences, Incivek, lupus, MS, Nuedexta, PBA, prostate cancer, Provenge, Vertex Pharmaceuticals
5 Biotech Takeover / LBO Targets With Bullish Short Trends
Seeking Alpha
Sat, 07/16/11 - 11:39 am
tags: Acorda Therapeutics, Dendreon, Exelixis, InterMune, Savient
July Catalysts for Biotech and Drug Stocks
Minyanville
Tue, 07/05/11 - 9:58 am
tags: Acorda Therapeutics, advisory panels, Amgen, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, FDA, GSK, Human Genome Sciences, JNJ, Merck, Seattle Genetics, Theravance, Transcept

Last 30 twitter posts

Latest Health Message Board Posts

Looking into treatment now i've been diagnosed..
... go and they wanted to confirm my shipping address. They then said my co-pay was $40/month! I confirmed my shipping information :-) Acorda Therapeutics, the maker of Ampyra, has a policy/program that ensures that no one pay more than $40 co-pay/month. Kyle
Posted by: Nikodicreta at 2013-01-04 06:00:00 on medhelp.org
Ampyra Cost Adjustment
... Addressing Walking Impairment AMPYRA Previously Referred to as Fampridine-SR AMPYRA Expected to be Available by Prescription in March 2010 Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has received marketing approval from the U.S. Food ...
Posted by: kwarendorf at 2012-07-11 05:00:00 on medhelp.org
FDA Approves Dalfampridine To Improve Walking In Multiple Sclerosis
For a somewhat less glowing assessment: http://industry.bnet.com/pharma/10006294/acorda-therapeutics-ms-drug-ampyra-could-stumble/ Note also that at the end of the article, they anticipate the annual price tag to be at least $10,000. sho
Posted by: Forum Admin at 2010-02-03 00:46:00 on depressionforums.org
FDA approves drug for MS walking problems
... membership, Antisense Therapeutics Ltd, BCDecker, Novartis Pharmaceuticals, Sanofi-Aventis, Teva Pharmaceuticals, Eli Lilly, UCB; consultancy, Genentech, Novartis Pharmaceuticals, Sanofi-Aventis, Teva Neuroscience, Teva Pharmaceuticals, Acorda, Acetilon ...
Posted by: shoshin at 2010-01-26 06:00:00 on medhelp.org
FDA approves drug for MS walking problems
... , a spokesperson for the FDA confirmed. It will be manufactured under licenses from Elan of Dublin, Ireland, and distributed by Acorda Therapeutics Inc of Hawthorne, New York. Given at doses greater than the recommended 10 mg twice a day, dalfampridine can ...
Posted by: Lulu54 at 2010-01-23 06:00:00 on medhelp.org